IMM 1.59% 31.0¢ immutep limited

igcs abstract, page-20

  1. 2,733 Posts.
    lightbulb Created with Sketch. 11
    Interesting read on another ovarian cancer trial.

    http://www.equities.com/news/headline-story?dt=2012-10-09&val=570138&cat=hcare

    Nice to see the research that is going on for patients with ovarian cancer.

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.